glp-1 cirrhosis Frontiers Alimentary Pharmacology & Therapeutics |
Description
, Draper, S
Taken together, with the overlap between OA risk factors and the metabolic syndrome, the demonstrated anti-inflammatory activities of GLP-1 in several tissues [10] and the expression of GLP-1R in joint tissues, GLP-1 analogues may be good therapeutic candidates for treating OA
There are several important considerations in structuring this benefit: First, real-world data show high discontinuation rates for GLP-1s, often due to side effects or other challenges, before full benefits are realized
Solini A, Giannini L, Seghieri M, et al
